Genix Pharmaceuticals Corp.

Genix Pharmaceuticals Corp. is a Canadian life sciences company specializing in the research, development, manufacturing, and distribution of both branded and generic pharmaceuticals, with a distinct focus on ophthalmic drugs and over-the-counter eye health products. The company’s product lineup includes prescription-based and OTC therapies aimed at treating and preventing various eye health issues and diseases, such as eye drops containing ketorolac, timolol, diclofenac, moxifloxacin, prednisolone acetate, olopatadine, and artificial tears. Beyond pharmaceuticals, Genix Pharmaceuticals also formulates and markets nutraceuticals and health supplements, including marine lipid and herbal-based products. With a commitment to safety, efficacy, and evidence-based formulations, Genix Pharmaceuticals serves both Canadian and global markets, working to expand the accessibility of high-quality, cost-effective medicines. The company’s activities play a significant role in supporting more affordable healthcare by increasing the availability of generic drugs, particularly in the ophthalmic sector, and addressing unmet needs in eye health care.